Abbott (NYSE:ABT) released earnings on June 30, 2005.
Income Statement Highlights (What's this?)
| Avg. Est. | Q2 2005 | Q2 2004 | % Change | |
|---|---|---|---|---|
| Sales | $5,280,000 | $5,523,800 | $4,703,049 | +17.5% |
| Net Profit | -- | $877,052 | $634,258 | +38.3% |
| EPS | $0.57 | $0.56 | $0.40 | +40.0% |
Margin Checkup (What's this?)
| Q2 2005 | Q2 2004 | % Change | |
|---|---|---|---|
| Gross Margin | 52.35% | 56.01% | -3.66% |
| Op. Margin | 19.82% | 16.93% | +2.89% |
| Net Margin | 15.88% | 13.49% | +2.39% |
Balance Sheet Highlights (What's this?)
No balance sheet provided.
Related Companies:
- Pfizer (NYSE:PFE)
- Merck (NYSE:MRK)
- Eli Lilly (NYSE:LLY)
- Bristol-Myers Squibb (NYSE:BMY)
- Schering-Plough (NYSE:SGP)
Related Foolishness:
If you would like our Foolish analysis of similar companies, why not take a 30-day free trial to Motley Fool Rule Breakers?
Fool by Numbers is designed to give you the raw earnings information in a timely fashion, putting all the numbers you need in one easy-to-read place. But at The Motley Fool, we believe numbers tell only part of the story, so check Fool.com for more of our in-depth discussion of what the numbers mean.
At the time of publication, John Reeves did not own shares in any of the companies mentioned. Fool rules are here.
